Marco Siccardi Selected Research

Marco Siccardi Research Topics

Disease

4	COVID-19 01/2022 - 01/2020
4	Malaria 01/2020 - 01/2013
4	Body Weight (Weight, Body) 01/2020 - 06/2011
3	Coinfection 10/2018 - 01/2014
2	HIV Infections (HIV Infection) 01/2021 - 01/2020
2	Infections 11/2013 - 01/2008
1	Liver Diseases (Liver Disease) 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Cerebral Malaria 01/2022
1	Lactic Acidosis 01/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Seizures (Absence Seizure) 01/2022
1	Fatigue 11/2019
1	Orthostatic Hypotension (Postural Hypotension) 05/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 10/2016
1	Metrorrhagia (Spotting) 02/2015
1	Fever (Fevers) 01/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015
1	Postpartum Hemorrhage 01/2015
1	Hemolytic Anemia 04/2012
1	Anemia 04/2012
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2012
1	Obesity 01/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 06/2009
1	Pseudarthrosis (Pseudoarthrosis) 01/2008

Drug/Important Bio-Agent (IBA)

4	Ritonavir (Norvir)FDA Link 01/2022 - 01/2020
4	efavirenz (Sustiva)FDA Link 10/2018 - 01/2015
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2014
3	Lopinavir FDA Link 03/2021 - 01/2020
2	Quinine (Quinson)FDA Link 01/2022 - 01/2020
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2022 - 03/2021
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 03/2021
2	Ribavirin (Virazole)FDA LinkGeneric 03/2021 - 04/2012
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 03/2021 - 12/2020
2	Lumefantrine FDA Link 01/2020 - 10/2018
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2020 - 06/2011
2	Nevirapine (Viramune)FDA Link 01/2012 - 06/2011
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2022
1	sarilumabIBA 03/2021
1	remdesivirIBA 03/2021
1	favipiravirIBA 03/2021
1	tocilizumab (atlizumab)FDA Link 03/2021
1	Antiviral Agents (Antivirals)IBA 03/2021
1	Interferon-betaIBA 03/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 03/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 03/2021
1	Delayed-Action PreparationsIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 12/2020
1	AmberIBA 12/2020
1	dolutegravirIBA 01/2020
1	Integrase InhibitorsIBA 01/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2019
1	Drug CombinationsIBA 01/2019
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 10/2018
1	Proteins (Proteins, Gene)FDA Link 02/2015
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2015
1	Misoprostol (Cytotec)FDA LinkGeneric 01/2015
1	RifamycinsIBA 01/2014
1	Reverse Transcriptase InhibitorsIBA 11/2013
1	Rilpivirine (TMC-278)IBA 11/2013
1	Artemether FDA Link 01/2013
1	InterferonsIBA 04/2012
1	Inosine TriphosphataseIBA 04/2012
1	Tyrosine Kinase InhibitorsIBA 06/2009
1	nilotinib FDA Link 06/2009
1	Dasatinib (BMS 354825)FDA Link 06/2009
1	Imatinib Mesylate (Gleevec)FDA Link 06/2009
1	GlycopeptidesIBA 01/2008
1	Vancomycin FDA LinkGeneric 01/2008
1	Methicillin (Metin)FDA Link 01/2008
1	TeicoplaninIBA 01/2008

Therapy/Procedure

10	Therapeutics 03/2021 - 01/2012
1	Duration of Therapy 03/2021
1	Investigational Therapies (Experimental Therapy) 12/2020
1	Oral Administration 01/2019
1	Debridement 01/2008